{"name":"Nacuity Pharmaceuticals, Inc.","slug":"nacuity-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Ophthalmology","slug":"ophthalmology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"N-Acetylcysteine Amide","genericName":"N-Acetylcysteine Amide","slug":"n-acetylcysteine-amide","indication":"Dry age-related macular degeneration (AMD)","status":"phase_3"}]}],"pipeline":[{"name":"N-Acetylcysteine Amide","genericName":"N-Acetylcysteine Amide","slug":"n-acetylcysteine-amide","phase":"phase_3","mechanism":"N-Acetylcysteine Amide (NACA) acts as a free radical scavenger and antioxidant that replenishes intracellular glutathione to protect cells from oxidative stress.","indications":["Dry age-related macular degeneration (AMD)","Retinal dystrophies and inherited retinal diseases"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2025-06-26","type":"pipeline","source":"GlobeNewswire","summary":"Retinitis Pigmentosa Research Report 2025: $25+ Bn Market - GlobeNewswire","headline":"Retinitis Pigmentosa Research Report 2025: $25+ Bn Market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgJBVV95cUxOYlE1bDB1YnJCNjQ0QVBTMWdxb1ZwXzhLTFQ5ZHhEbWxWbnF1U2g1OGFydDlWYW1Pb1I2WklXdzNXZkhSSmFCUGVEX3ZWemg3VmhoSXd6WlY3X3JqZHpLYnZGY3JQWVdKOEcybWQzRHhyamFDSDJBckcxYngyd3hTS1kza0RqbXR2SVR2dnkyOGZWQ0ZXVzV0bXpzcF9UenFvRmFVQnlZU3NuaHlEcG10SHY0Z0pxOG1rdjQ2WGpSZnAxYWFFQjBENkZwNHMxc190S1dNdGE2Y3ZlZ21fVWV2OTJtX2NSaEd5Vm1nLTBpMGpsRnRnVFVHNmRNVUZ5NkhvX2pXaXlDQ0wwckEwR2c?oc=5","date":"2025-04-09","type":"pipeline","source":"businesswire.com","summary":"Aviceda Therapeutics Appoints Ophthalmology Innovator and Industry Leader Dr. Emmett T. Cunningham, Jr. to Board of Directors - businesswire.com","headline":"Aviceda Therapeutics Appoints Ophthalmology Innovator and Industry Leader Dr. Emmett T. Cunningham, Jr. to Board of Dire","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxPcFBzejFhdXNwbjRlYm84bk5Yd3RVUVBDWVRMbTZTRnZDb1dUa2l1cEtCbWZFUWlocXcwYjZGSkI3b1ktajdXdGNzZEEyVEYtdlFKcENxUFMxZnZGNGhteUhIY2Vrb19qOGQtSDFsMk1wR1UzTTFDYmVBQjQ0c2duMDVKcGlvWUdOY0tmN05keEhnd0J5STRWRnpfcmJudzBXRDhpSm5IV210WE03a1RQcENsNnhxQk5YckRNU01hNVQxY2M?oc=5","date":"2025-01-22","type":"regulatory","source":"Eyes On Eyecare","summary":"FDA grants Nacuity Pharmaceuticals Fast Track designation for RP tablets - Eyes On Eyecare","headline":"FDA grants Nacuity Pharmaceuticals Fast Track designation for RP tablets","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwJBVV95cUxOWnFwcEFyaWluNXNacFJfeWQ2NVdsUjEzRG1YeS1TWDUzQ01vYzBtN1lSOHNZMGRjREktdEdBOWV6U2l6QUwtLTI0MVFpekxyTFM0NDZVSkJmN0RKSlZ5bWRDMnNCeWJjNGtER3hJaUE1YjdyVExDeEdEamd2Mi1LcncyTDBHdl9tdl9YWlRXSEh0ZERXVzRTMEkzbkY3V29CMmFVdW1uV2p3NHNkVmNXdE9aUDU1VGV4ZGVXeVpFVXVJY1dydjIxclA3MkFkeGlvem9SUjB0dlRFZlBlWXJ5NDFCalBpSmk5VkhpUl9fT3pHSUdGZGU1YTRhSzZwWnNMQUlCWkZLSXJGbE1mX1NZ?oc=5","date":"2024-11-19","type":"pipeline","source":"GlobeNewswire","summary":"Advancing Stargardt Disease Treatments: 20+ Companies Poised to Accelerate the Therapeutic Pipeline | DelveInsight - GlobeNewswire","headline":"Advancing Stargardt Disease Treatments: 20+ Companies Poised to Accelerate the Therapeutic Pipeline | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxOMlBwS1Q5U3VDYVROSTF3akJWcDRxNkVHcldHSVdYQWNzOHJkRTlSckJoYmpsX2RZazF1WkpqdVRUb0JaT1p0Qlg0TU5Yd1NQZjFqcGVJbnVYcnUwR3hJem83dzJKcVNYSW9fMFE4VU9JS1dQVkxWTGFpVkxTQkJjWlZJZlFid2Q4VWhv?oc=5","date":"2024-06-07","type":"pipeline","source":"Dallas Innovates","summary":"Irving’s McKesson Corp. Adds Healthcare Veteran to Board - Dallas Innovates","headline":"Irving’s McKesson Corp. Adds Healthcare Veteran to Board","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxOMnF4QmhHaFd5YXVKU2J0RmdxY0NYcTBRMmxEXzlRbUxGVjBCWldJb2dsLVNJQjdvT3VzREs1Z0dSMDdiQm5rOXZHa2g2SF9uem92WUprMnpDTzRWSjU0Q1kxU1Q0a2lDZGNfNDVBQnlZNThwcmtPRGVYY0hzY2NaMDA5cmlzM0xXMXNGWTRtYi1NdFRHeWc?oc=5","date":"2024-04-19","type":"pipeline","source":"Dallas Innovates","summary":"Opthalmic Industry Veteran Joins Nacuity Pharmaceuticals’ Board - Dallas Innovates","headline":"Opthalmic Industry Veteran Joins Nacuity Pharmaceuticals’ Board","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgJBVV95cUxNY0F6dWlrZk5DekFxRG15YnljVkV0QkV2N21pTlFkUUJtcWdwSjFpYTNFVHFlVzVBcTVjMTdZUzhfNTNLY3JNOW5LN0dnRWh4ZmZOeUROb2FuNUd2NVFqMXlmQnVlUWk4MzduQ3REbzFlQ0dzdXV0N3JZUHMyQnBJOFU4V2RlRzE3a25ldkc5TnljU0RsYVAwc2wzRVg4S2gwSEoyeUlHWUNoSDhMcVFWYTRPNHBnRDFpdEJOZHFRa3RXVWZoTGYxLWRyYWlCSDFKRTRBTGg1cHdMZ3llVzRvcXF1RmpUbVRpa1NXWmpMWnk5ajNvN0VHdXZCTXFzOTVQZlE3dVlKTVVVSk1RVG9oZ3hfd1JoMUttTG11YncxSXVvVzc0aF8xMTRobHdRVHZKM0NuRFZjbmpHLXEwdVhHMnk3dTdrLWEyMV92Tnp3?oc=5","date":"2024-02-19","type":"trial","source":"GlobeNewswire","summary":"Gene Therapies In Ophthalmology Clinical Trial Pipeline - GlobeNewswire","headline":"Gene Therapies In Ophthalmology Clinical Trial Pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxPT0ZXTWhldW9sT3V3M1BPZjFoaVAtNjllWUR0VWUxTUdtMkJIbXltZENxUjlITTB3TGxYcDI5bHRNQ3ZPOXM3MnJuLXFOczB5QWJMRjN0ajdJYnRaVUFRVmJaSEpFTGhKWjhFTFpoV0NiTW1QelF2WjJNSGpOYm8tNTFKUlU1MHJRQmx6RGlhcllfeWdXQUk4dm0xV3J6cnFiWjZGWWxFQy1DMmw4Vy0zM2d0MVhZcGxBdG5BQXVRcnZaNG9F?oc=5","date":"2023-06-01","type":"trial","source":"Eyes On Eyecare","summary":"Target enrollment achieved in trial for RP associated with Usher syndrome - Eyes On Eyecare","headline":"Target enrollment achieved in trial for RP associated with Usher syndrome","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE1xNURfNVYyYWtzMlVqTnhaczZ2d1Y3b0hqc09ZcXo4RlB2dHdzWUYyRFpXdlR0LXZSNldXOVF0Y3hlTHNwZHdqVWNNTW1QWVcwRUMyVGhTMVdST3lIaGNDeURRZ25DU0xaMVlqMg?oc=5","date":"2022-06-09","type":"pipeline","source":"BioSpace","summary":"BioSpace Movers & Shakers: Third Harmonic, Inozyme, Athira, Aurion and More - BioSpace","headline":"BioSpace Movers & Shakers: Third Harmonic, Inozyme, Athira, Aurion and More","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPY2pJb2VOS194U2pPOXNpb2tqOWFpYnFIUXZ3Mm94NDFIQVNqbTU4Qm1QQXEyZWhtQUNYTmdfc3FNc1JYOGgybUhjUUlIaVh5ZGo0d3FVR3c3RGpUVXFzRVNZQjlMQ2JRVEZyQnNzeTh5UE4wSUlvel9FVXJCdFhCVm5VZFFONTBqTXV2UkVOdk1Zd1hhNDJXYzZfaTBjQQ?oc=5","date":"2020-01-22","type":"pipeline","source":"Dallas Innovates","summary":"13 Companies and Organizations Spawned by Alcon Alumni - Dallas Innovates","headline":"13 Companies and Organizations Spawned by Alcon Alumni","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}